The Patent Finder

Vasculox, Inc.

Also on record
Records under this name other than the patents Vasculox, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 5 of 5 · Back to Vasculox, Inc.

PatentTitleStatus Expires Confidence
US 11,292,834Therapeutic CD47 antibodies
Lapsed on the fee record
Ended Apr 5, 2026 · From the USPTO record
Lapsed on the fee recordEnded Apr 5, 2026From the USPTO record
US 9,518,116Therapeutic CD47 antibodies
Lapsed on the fee record
Ended Dec 13, 2024 · From the USPTO record
Lapsed on the fee recordEnded Dec 13, 2024From the USPTO record
US 9,518,117Therapeutic CD47 antibodies
Lapsed on the fee record
Ended Dec 13, 2024 · From the USPTO record
Lapsed on the fee recordEnded Dec 13, 2024From the USPTO record
US 10,676,524Therapeutic CD47 antibodies
Lapsed on the fee record
Ended Jun 9, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jun 9, 2024From the USPTO record
US 10,669,336Therapeutic CD47 antibodies
Lapsed on the fee record
Ended Jun 2, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jun 2, 2024From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited